Man Group PLC Novavax Inc Transaction History

Man Group PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.8 - $7.67 $144,480 - $230,867	-30,100 Reduced 53.66%	25,999 $124,000
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $139,598 - $199,660	20,499 Added 57.58%	56,099 $406,000
Q2 2023 Aug 14, 2023	SELL	$6.67 - $9.52 $24,719 - $35,281	-3,706 Reduced 9.43%	35,600 $264,000
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $226,402 - $490,538	39,306 New	39,306 $272,000
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $2.25 Million - $9.4 Million	123,502 Added 135.39%	214,722 $3.91 Million
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $3.12 Million - $6.47 Million	85,975 Added 1639.18%	91,220 $4.69 Million
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $3.51 Million - $7.19 Million	-50,298 Reduced 90.56%	5,245 $387,000
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $1.68 Million - $2.72 Million	12,469 Added 28.95%	55,543 $7.95 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $7.66 Million - $11.7 Million	43,074 New	43,074 $8.93 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $362,274 - $771,463	-2,994 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $1.27 Million - $3.58 Million	-11,203 Reduced 78.91%	2,994 $544,000
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $423,148 - $749,673	5,374 Added 60.91%	14,197 $1.58 Million
Q3 2020 Nov 16, 2020	SELL	$79.44 - $178.51 $9.56 Million - $21.5 Million	-120,361 Reduced 93.17%	8,823 $955,000
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $1.79 Million - $10.8 Million	129,184 New	129,184 $10.8 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.